HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
NCF4
neutrophil cytosolic factor 4
Chromosome 22 Β· 22q12.3
NCBI Gene: 4689Ensembl: ENSG00000100365.16HGNC: HGNC:7662UniProt: A0A494BZS1
89PubMed Papers
21Diseases
0Drugs
26Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
cytosolsuperoxide-generating NADPH oxidase activator activityphosphatidylinositol-3-phosphate bindingNADPH oxidase complexchronic granulomatous diseaseCrohn's diseaseinflammatory bowel diseasedermatitis
✦AI Summary

NCF4 (neutrophil cytosolic factor 4, also termed p40phox) is a subunit of the phagocyte NADPH oxidase complex that mediates electron transfer from cytosolic NADPH to oxygen to produce superoxide anion (O2βˆ’), a critical component of the respiratory burst required for pathogen killing 1. The protein functions as part of a multi-protein complex where electrons are transferred sequentially through FAD and heme molecules to generate reactive oxygen species 1. NCF4 exhibits dual functionality beyond canonical oxidase assembly: it regulates inflammasome activation by promoting NLRP3 and AIM2 complex assembly through ROS-dependent sensing and acts as a spatial regulator of inflammasome positioning 2. Additionally, NCF4-dependent intracellular ROS maintains cysteine peptides in an oxidized state, regulating antigen presentation and restricting autoreactive T cell activation 3. Genetically, NCF4 deficiency causes chr22 granulomatous disease (CGD), an atypical, mild form presenting as immunodeficiency without typical invasive infections seen in other CGD variants 4. NCF4 polymorphisms (rs4821544, rs729749) are associated with rheumatoid arthritis susceptibility in Chinese populations 5. Clinically, reduced NCF4 expression correlates with colorectal cancer development and decreased survival 2. NCF4 is also implicated as an oxidative stress and immune-related biomarker in atherosclerosis 6. These findings establish NCF4 as essential for both innate immunity and immune homeostasis 7.

Sources cited
1
NCF4 is a subunit of phagocyte NADPH oxidase that generates superoxide for pathogen killing
PMID: 31172494
2
NCF4 promotes NLRP3 and AIM2 inflammasome activation and functions in colorectal cancer suppression
PMID: 38886341
3
NCF4-dependent ROS oxidizes cysteine peptides to regulate antigen presentation and prevent arthritogenic T cell activation
PMID: 38547647
4
NCF4 deficiency causes a mild, atypical form of chronic granulomatous disease
PMID: 32524254
5
NCF4 polymorphisms rs4821544 and rs729749 are associated with rheumatoid arthritis susceptibility
PMID: 33145364
6
NCF4 is identified as a diagnostic marker of atherosclerosis and oxidative stress
PMID: 36035208
7
NCF4 is an IBD susceptibility gene involved in neutrophil defense functions and gut immunity
PMID: 38110547
Disease Associationsβ“˜21
chronic granulomatous diseaseOpen Targets
0.66Moderate
Crohn's diseaseOpen Targets
0.44Moderate
inflammatory bowel diseaseOpen Targets
0.44Moderate
dermatitisOpen Targets
0.39Weak
psoriasisOpen Targets
0.34Weak
atopic eczemaOpen Targets
0.31Weak
asthmaOpen Targets
0.31Weak
multiple sclerosisOpen Targets
0.31Weak
Eczematoid dermatitisOpen Targets
0.31Weak
respiratory system diseaseOpen Targets
0.31Weak
diabetic ketoacidosisOpen Targets
0.14Weak
Immunodeficiency due to a late component of complements deficiencyOpen Targets
0.08Suggestive
Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiencyOpen Targets
0.08Suggestive
Autosomal recessive hyper-IgE syndromeOpen Targets
0.07Suggestive
Autosomal recessive hyper-IgE syndrome due to TYK2 deficiencyOpen Targets
0.07Suggestive
immunodeficiency 35Open Targets
0.07Suggestive
X-linked severe congenital neutropeniaOpen Targets
0.07Suggestive
Recurrent infection due to specific granule deficiencyOpen Targets
0.07Suggestive
isolated agammaglobulinemiaOpen Targets
0.07Suggestive
immunodeficiency 86Open Targets
0.07Suggestive
Granulomatous disease, chronic, autosomal recessive, 3UniProt
Pathogenic Variants26
NM_000631.5(NCF4):c.529-2A>TPathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜…β˜†β˜†2026
NM_000631.5(NCF4):c.758+50C>TPathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2026
NM_000631.5(NCF4):c.118-1G>APathogenic
not provided|Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜…β˜†β˜†2025
NM_000631.5(NCF4):c.614_615del (p.Lys205fs)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜…β˜†β˜†2025β†’ Residue 205
NM_000631.5(NCF4):c.759-40C>TPathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2025
NM_000631.5(NCF4):c.314G>A (p.Arg105Gln)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3|Chronic granulomatous disease
β˜…β˜…β˜†β˜†2024β†’ Residue 105
NC_000022.11:g.36864921_36864935delLikely pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜…β˜†β˜†2024
NM_000631.5(NCF4):c.143_152dup (p.Lys52fs)Pathogenic
Chronic granulomatous disease|Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜†β˜†β˜†2026β†’ Residue 52
NM_000631.5(NCF4):c.771G>A (p.Val257=)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜†β˜†β˜†2025β†’ Residue 257
NM_000631.5(NCF4):c.456del (p.Arg153fs)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜†β˜†β˜†2025β†’ Residue 153
NM_000631.5(NCF4):c.256del (p.Leu86fs)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜†β˜†β˜†2025β†’ Residue 86
NM_000631.5(NCF4):c.32+2T>CLikely pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜†β˜†β˜†2024
NM_000631.5(NCF4):c.470+2T>GLikely pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜†β˜†β˜†2024
NM_000631.5(NCF4):c.3G>A (p.Met1Ile)Likely pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜†β˜†β˜†2024β†’ Residue 1
NM_000631.5(NCF4):c.13C>T (p.Gln5Ter)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜†β˜†β˜†2024β†’ Residue 5
NM_000631.5(NCF4):c.758+36_758+81delPathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜†β˜†β˜†2023
NM_000631.5(NCF4):c.367del (p.Val123fs)Pathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜†β˜†β˜†2023β†’ Residue 123
NM_000631.5(NCF4):c.471-1G>ALikely pathogenic
Chronic granulomatous disease
β˜…β˜†β˜†β˜†2023
NM_000631.5(NCF4):c.759-24T>GPathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜†β˜†β˜†2023
NM_000631.5(NCF4):c.759-19C>TPathogenic
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3
β˜…β˜†β˜†β˜†2022
View on ClinVar β†—
Related Genes
MAPK14Protein interaction100%NOX4Protein interaction99%DUOX1Protein interaction99%NOX5Protein interaction99%VAV1Protein interaction98%RAP1AProtein interaction95%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
53%
Liver
8%
Heart
4%
Ovary
2%
Brain
1%
Gene Interaction Network
Click a node to explore
NCF4MAPK14NOX4DUOX1NOX5VAV1RAP1A
PROTEIN STRUCTURE
Preparing viewer…
PDB1W70 Β· 1.46 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.00LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.74 [0.55–1.00]
RankingsWhere NCF4 stands among ~20K protein-coding genes
  • #5,369of 20,598
    Most Researched89
  • #1,943of 5,498
    Most Pathogenic Variants26
  • #9,745of 17,882
    Most Constrained (LOEUF)1.00
Genes detectedNCF4
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Chronic Granulomatous Disease: a Comprehensive Review.
PMID: 32524254
Clin Rev Allergy Immunol Β· 2021
1.00
2
Neutrophils: from IBD to the gut microbiota.
PMID: 38110547
Nat Rev Gastroenterol Hepatol Β· 2024
0.90
3
NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance.
PMID: 38886341
Nat Commun Β· 2024
0.80
4
Novel Diagnostic Biomarkers Related to Oxidative Stress and Macrophage Ferroptosis in Atherosclerosis.
PMID: 36035208
Oxid Med Cell Longev Β· 2022
0.70
5
Association of
PMID: 33145364
J Immunol Res Β· 2020
0.60